Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6948-6953
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6948
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6948
Table 4 Baseline characteristics of patients treated for 2 years1
| Total (range) | SR-ALT | NR-ALT | SR-DN | NR-DNA | |
| n | 147 | 75 | 72 | 85 | 62 |
| Male/female | 112/35 | 52/23 | Dec-60 | 62/23 | Dec-50 |
| ALT (U/L) | 221.6±493.5 (17-4491) | 258.9±548.5 | 182.3±428.2 | 291.3±626.3 | 122.2±132.0 |
| Albumin (g/dL) | 3.8±0.6 (2.2-4.9) | 3.8±0.5 | 3.8±0.6 | 3.8±0.5 | 3.9±0.6 |
| Bilirubin (mg/dL) | 1.5±2.1 (0.3-12.9) | 1.7±2.5 | 1.3±1.7 | 1.7±2.6 | 1.0±1.1 |
| Platelet (104/mL) | 13.8±6.2 (3.4-33.6) | 12.9±5.4 | 14.6±6.8 | 13.1±5.5 | 14.9±5.6 |
| BSA (m2) | 1.71±0.18 (1.30-2.17) | 1.67±0.18 | 1.76±0.17 | 1.70±0.18 | 1.73±0.18 |
| HBV-DNA | |||||
| ≤5 (LEG/mL) | 18 | 11 | 7 | 12 | 6 |
| 5< ≤6 | 20 | 7 | 13 | 11 | 9 |
| 6< ≤7 | 42 | 23 | 19 | 26 | 16 |
| 7< | 69 | 35 | 34 | 38 | 31 |
| HBeAg +/– | 82/65 | 41/34 | 41/31 | 41/45 | 41/20 |
| Age (yr) | 48.9±11.4 (19-73) | ||||
| CH/LC [Child A/B/C] | 95/54 [43/3/8] |
- Citation: Nakamuta M, Morizono S, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Furusyo N, Nomura H, Sakai H, Takahashi K, Azuma K, Shimoda S, Kotoh K, Enjoji M, Group JHKULDS. Relationship between body surface area and ALT normalization after long-term lamivudine treatment. World J Gastroenterol 2005; 11(44): 6948-6953
- URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6948.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i44.6948